GSO ISO 15189:2024
ISO 15189:2022
Gulf Standard
Current Edition
·
Approved on
14 October 2024
Medical laboratories — Requirements for quality and competence
GSO ISO 15189:2024 Files
No files are available for this standard right now!
GSO ISO 15189:2024 Scope
This document specifies requirements for quality and competence in medical laboratories.
This document is applicable to medical laboratories in developing their management systems and assessing their competence. It is also applicable for confirming or recognizing the competence of medical laboratories by laboratory users, regulatory authorities and accreditation bodies.
This document is also applicable to point-of-care testing (POCT).
NOTE International, national, or regional regulations or requirements can also apply to specific topics covered in this document.
Best Sellers From Health Sector
GSO 2017:2023
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 1223:2023
Gulf Standard
Cosmetic Products-Deodorants
Recently Published from Health Sector
GSO ISO 20776-2:2024
ISO 20776-2:2021
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems
— Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices
— Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution
GSO ISO 27186:2024
ISO 27186:2020
Gulf Standard
Active implantable medical devices — Four-pole connector system for implantable cardiac rhythm management devices — Dimensional and test requirements
GSO ISO 28620:2024
ISO 28620:2020
Gulf Standard
Medical devices
— Non-electrically driven portable infusion devices
GSO ISO 20776-1:2024
ISO 20776-1:2019
Gulf Standard
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices
— Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases